{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:44:26Z","timestamp":1790192666361,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS082145"],"award-info":[{"award-number":["T32NS082145"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG076030"],"award-info":[{"award-number":["R01AG076030"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG076030"],"award-info":[{"award-number":["R01AG076030"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"San Antonio Nathan Shock Center of Excellence Pilot Grant"},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004693"],"award-info":[{"award-number":["BX004693"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07164-y","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:33:20Z","timestamp":1789112000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enantiomer-specific modulation of GABAA receptors differentially regulates stress-induced dopamine dysregulation"],"prefix":"10.1007","author":[{"given":"Kayla","family":"Lilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithu","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"Suppl 1","key":"7164_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S1461145704004110","volume":"7","author":"A Abi-Dargham","year":"2004","unstructured":"Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1\u20135","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"7164_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41386-022-01360-y","volume":"47","author":"A Bernardo","year":"2022","unstructured":"Bernardo A, Lee P, Marcotte M, Mian MY, Rezvanian S, Sharmin D, Kovacevic A, Savic MM, Cook JM, Sibille E, Prevot TD (2022) Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress. Neuropsychopharmacology 47(9):1608\u20131619","journal-title":"Neuropsychopharmacology"},{"key":"7164_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2024.12.001","volume":"147","author":"AM Bernardo","year":"2024","unstructured":"Bernardo AM, Marcotte M, Wong K, Sharmin D, Pandey KP, Cook JM, Sibille EL, Prevot TD (2024) Procognitive and neurotrophic benefits of alpha5-GABA-A receptor positive allosteric modulation in a beta-amyloid deposition mouse model of Alzheimer\u2019s disease pathology. Neurobiol Aging 147:49\u201359","journal-title":"Neurobiol Aging"},{"issue":"1","key":"7164_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/jn.00539.2013","volume":"113","author":"EP Christian","year":"2015","unstructured":"Christian EP, Snyder DH, Song W, Gurley DA, Smolka J, Maier DL, Ding M, Gharahdaghi F, Liu XF, Chopra M, Ribadeneira M, Chapdelaine MJ, Dudley A, Arriza JL, Maciag C, Quirk MC, Doherty JJ (2015) EEG-beta\/gamma spectral power elevation in rat: a translatable biomarker elicited by GABA(Aalpha2\/3)-positive allosteric modulators at nonsedating anxiolytic doses. J Neurophysiol 113(1):116\u2013131","journal-title":"J Neurophysiol"},{"key":"7164_CR7","unstructured":"Department of Veterans Affairs, D. o. D. (26 (2025) March What is PTSD? Retrieved 11 July, 2025"},{"key":"7164_CR6","unstructured":"Department of Veterans Affairs, D. o. D. (26 (2025) March How Common is PTSD in Adults? Retrieved 11 July, 2025"},{"issue":"46","key":"7164_CR8","doi-asserted-by":"publisher","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","volume":"25","author":"R Dias","year":"2005","unstructured":"Dias R, Sheppard WF, Fradley RL, Garrett EM, Stanley JL, Tye SJ, Goodacre S, Lincoln RJ, Cook SM, Conley R, Hallett D, Humphries AC, Thompson SA, Wafford KA, Street LJ, Castro JL, Whiting PJ, Rosahl TW, Atack JR, McKernan RM, Dawson GR, Reynolds DS (2005) Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J Neurosci 25(46):10682\u201310688","journal-title":"J Neurosci"},{"key":"7164_CR9","doi-asserted-by":"crossref","unstructured":"Eassa NE, Perez SM, Boley AM, Elam HB, Sharmin D, Cook JM, Lodge DJ (2023) alpha5-GABAA receptor modulation reverses behavioral and neurophysiological correlates of psychosis in rats with ventral hippocampal alzheimer\u2019s disease-like pathology. Int J Mol Sci 24(14)","DOI":"10.3390\/ijms241411788"},{"issue":"1","key":"7164_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41398-021-01235-8","volume":"11","author":"HB Elam","year":"2021","unstructured":"Elam HB, Perez SM, Donegan JJ, Lodge DJ (2021) Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis. Transl Psychiatry 11(1):114","journal-title":"Transl Psychiatry"},{"issue":"8","key":"7164_CR11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","volume":"39","author":"E Engin","year":"2018","unstructured":"Engin E, Benham RS, Rudolph U (2018) An Emerging Circuit Pharmacology of GABA(A) Receptors. Trends Pharmacol Sci 39(8):710\u2013732","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"7164_CR12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0022-3565(25)11126-9","volume":"261","author":"M Facklam","year":"1992","unstructured":"Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE (1992) Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J Pharmacol Exp Ther 261(3):1113\u20131121","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"7164_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrn1625","volume":"6","author":"M Farrant","year":"2005","unstructured":"Farrant M, Nusser Z (2005) Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6(3):215\u2013229","journal-title":"Nat Rev Neurosci"},{"issue":"13","key":"7164_CR14","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1523\/JNEUROSCI.21-13-04915.2001","volume":"21","author":"SB Floresco","year":"2001","unstructured":"Floresco SB, Todd CL, Grace AA (2001) Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 21(13):4915\u20134922","journal-title":"J Neurosci"},{"issue":"9","key":"7164_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nn1103","volume":"6","author":"SB Floresco","year":"2003","unstructured":"Floresco SB, West AR, Ash B, Moore H, Grace AA (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6(9):968\u2013973","journal-title":"Nat Neurosci"},{"issue":"1","key":"7164_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cne.903590111","volume":"359","author":"JM Fritschy","year":"1995","unstructured":"Fritschy JM, Mohler H (1995) GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359(1):154\u2013194","journal-title":"J Comp Neurol"},{"issue":"1","key":"7164_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molbrainres.2005.03.013","volume":"138","author":"J Fujimura","year":"2005","unstructured":"Fujimura J, Nagano M, Suzuki H (2005) Differential expression of GABA(A) receptor subunits in the distinct nuclei of the rat amygdala. Brain Res Mol Brain Res 138(1):17\u201323","journal-title":"Brain Res Mol Brain Res"},{"key":"7164_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.12659\/MSM.890589","volume":"20","author":"J Gao","year":"2014","unstructured":"Gao J, Wang H, Liu Y, Li YY, Chen C, Liu LM, Wu YM, Li S, Yang C (2014) Glutamate and GABA imbalance promotes neuronal apoptosis in hippocampus after stress. Med Sci Monit 20:499\u2013512","journal-title":"Med Sci Monit"},{"issue":"9","key":"7164_CR19","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/npp.2011.76","volume":"36","author":"KM Gill","year":"2011","unstructured":"Gill KM, Lodge DJ, Cook JM, Aras S, Grace AA (2011) A novel alpha5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. Neuropsychopharmacology 36(9):1903\u20131911","journal-title":"Neuropsychopharmacology"},{"key":"7164_CR20","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/j.ynstr.2021.100335","volume":"15","author":"ST Gonzalez","year":"2021","unstructured":"Gonzalez ST, Marty V, Spigelman I, Reise SP, Fanselow MS (2021) Impact of stress resilience and susceptibility on fear learning, anxiety, and alcohol intake. Neurobiol Stress 15:100335","journal-title":"Neurobiol Stress"},{"issue":"1","key":"7164_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","volume":"41","author":"AA Grace","year":"1991","unstructured":"Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41(1):1\u201324","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"7164_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0165-0173(99)00049-1","volume":"31","author":"AA Grace","year":"2000","unstructured":"Grace AA (2000) Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 31(2\u20133):330\u2013341","journal-title":"Brain Res Brain Res Rev"},{"issue":"2","key":"7164_CR23","first-page":"333","volume":"10","author":"AA Grace","year":"1983","unstructured":"Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons\u20133. Evid electrotonic coupling Neurosci 10(2):333\u2013348","journal-title":"Evid electrotonic coupling Neurosci"},{"issue":"2","key":"7164_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0006-8993(85)91581-1","volume":"333","author":"AA Grace","year":"1985","unstructured":"Grace AA, Bunney BS (1985) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 333(2):271\u2013284","journal-title":"Brain Res"},{"issue":"5","key":"7164_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.tins.2007.03.003","volume":"30","author":"AA Grace","year":"2007","unstructured":"Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30(5):220\u2013227","journal-title":"Trends Neurosci"},{"issue":"1","key":"7164_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0306-4522(87)90275-2","volume":"23","author":"HJ Groenewegen","year":"1987","unstructured":"Groenewegen HJ, Vermeulen-Van der Zee E, te Kortschot A, Witter MP (1987) Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience 23(1):103\u2013120","journal-title":"Neuroscience"},{"issue":"4","key":"7164_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1113\/jphysiol.2012.243725","volume":"591","author":"TS Heistek","year":"2013","unstructured":"Heistek TS, Ruiperez-Alonso M, Timmerman AJ, Brussaard AB, Mansvelder HD (2013) alpha2-containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations. J Physiol 591(4):845\u2013858","journal-title":"J Physiol"},{"issue":"8","key":"7164_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment: Meta-analysisof imaging studies. Arch Gen Psychiatry 69(8):776\u2013786","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"7164_CR29","doi-asserted-by":"publisher","first-page":"e13357","DOI":"10.1111\/psyp.13357","volume":"57","author":"SA Joshi","year":"2020","unstructured":"Joshi SA, Duval ER, Kubat B, Liberzon I (2020) A review of hippocampal activation in post-traumatic stress disorder. Psychophysiology 57(1):e13357","journal-title":"Psychophysiology"},{"issue":"9","key":"7164_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1101\/lm.037291.114","volume":"22","author":"EJ Kim","year":"2015","unstructured":"Kim EJ, Pellman B, Kim JJ (2015) Stress effects on the hippocampus: a critical review. Learn Mem 22(9):411\u2013416","journal-title":"Learn Mem"},{"key":"7164_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coph.2021.04.003","volume":"59","author":"F Knoflach","year":"2021","unstructured":"Knoflach F, Bertrand D (2021) Pharmacological modulation of GABA(A) receptors. Curr Opin Pharmacol 59:3\u201310","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"7164_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/026988119901300405","volume":"13","author":"M Laruelle","year":"1999","unstructured":"Laruelle M, Abi-Dargham A (1999) Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 13(4):358\u2013371","journal-title":"J Psychopharmacol"},{"issue":"17","key":"7164_CR33","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1097\/WNR.0b013e328332bb09","volume":"20","author":"T Lee","year":"2009","unstructured":"Lee T, Jarome T, Li SJ, Kim JJ, Helmstetter FJ (2009) Chronic stress selectively reduces hippocampal volume in rats: a longitudinal magnetic resonance imaging study. NeuroReport 20(17):1554\u20131558","journal-title":"NeuroReport"},{"key":"7164_CR34","doi-asserted-by":"crossref","unstructured":"Liberzon I, Abelson JL (2016) Stress Disorder Neuron 92(1):14\u201330Context processing and the neurobiology of post-traumatic","DOI":"10.1016\/j.neuron.2016.09.039"},{"issue":"12","key":"7164_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Scott Stroup T, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209\u20131223","journal-title":"N Engl J Med"},{"key":"7164_CR36","unstructured":"Lilly K, Sharmin D, Cook JM, Lodge DJ, Perez SM (2026) Targeting \u03b15-GABAA receptors to restore dopamine system function in a translationally relevant model of perimenopausal psychosis. J Psychopharmacology, Manuscript in Revision"},{"issue":"7","key":"7164_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/sj.npp.1300963","volume":"31","author":"DJ Lodge","year":"2006","unstructured":"Lodge DJ, Grace AA (2006) The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31(7):1356\u20131361","journal-title":"Neuropsychopharmacology"},{"issue":"42","key":"7164_CR38","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","volume":"27","author":"DJ Lodge","year":"2007","unstructured":"Lodge DJ, Grace AA (2007) Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci 27(42):11424\u201311430","journal-title":"J Neurosci"},{"issue":"9","key":"7164_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tips.2011.05.001","volume":"32","author":"DJ Lodge","year":"2011","unstructured":"Lodge DJ, Grace AA (2011) Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci 32(9):507\u2013513","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"7164_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","volume":"44","author":"B Luscher","year":"2023","unstructured":"Luscher B, Maguire JL, Rudolph U, Sibille E (2023) GABA(A) receptors as targets for treating affective and cognitive symptoms of depression. Trends Pharmacol Sci 44(9):586\u2013600","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"7164_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/ijnp\/pyac035","volume":"25","author":"AM McCoy","year":"2022","unstructured":"McCoy AM, Prevot TD, Mian MY, Cook JM, Frazer A, Sibille EL, Carreno FR, Lodge DJ (2022) Positive Allosteric Modulation of alpha5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle. Int J Neuropsychopharmacol 25(8):688\u2013698","journal-title":"Int J Neuropsychopharmacol"},{"key":"7164_CR43","doi-asserted-by":"crossref","unstructured":"McCoy AM, Prevot TD, Sharmin D, Cook JM, Sibille EL, Lodge DJ (2023) GL-II-73, A positive allosteric modulator of alpha5gaba(a) receptors, reverses dopamine system dysfunction associated with pilocarpine-induced temporal lobe epilepsy. Int J Mol Sci 24(14)","DOI":"10.3390\/ijms241411588"},{"key":"7164_CR42","doi-asserted-by":"crossref","unstructured":"McCoy AM, Prevot TD, Mian MY, Sharmin D, Ahmad AN, Cook JM, Sibille EL, Lodge DJ (2024) Extrasynaptic localization is essential for alpha5GABA(A) receptor modulation of dopamine system function. eNeuro 11(3)","DOI":"10.1523\/ENEURO.0344-23.2023"},{"issue":"5\u20136","key":"7164_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00335-010-9266-6","volume":"21","author":"BH Miller","year":"2010","unstructured":"Miller BH, Schultz LE, Long BC, Pletcher MT (2010) Quantitative trait locus analysis identifies Gabra3 as a regulator of behavioral despair in mice. Mamm Genome 21(5\u20136):247\u2013257","journal-title":"Mamm Genome"},{"issue":"1","key":"7164_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","volume":"62","author":"H Mohler","year":"2012","unstructured":"Mohler H (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62(1):42\u201353","journal-title":"Neuropharmacology"},{"issue":"3","key":"7164_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S204579601400033X","volume":"23","author":"V Mondelli","year":"2014","unstructured":"Mondelli V (2014) From stress to psychosis: whom, how, when and why? Epidemiol Psychiatr Sci 23(3):215\u2013218","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"9","key":"7164_CR47","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/j.1460-9568.2006.04775.x","volume":"23","author":"HV Morris","year":"2006","unstructured":"Morris HV, Dawson GR, Reynolds DS, Atack JR, Stephens DN (2006) Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur J Neurosci 23(9):2495\u20132504","journal-title":"Eur J Neurosci"},{"key":"7164_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuropharm.2018.09.026","volume":"143","author":"E Neumann","year":"2018","unstructured":"Neumann E, Ralvenius WT, Acuna MA, Rudolph U, Zeilhofer HU (2018) TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via alpha2GABA(A) receptors. Neuropharmacology 143:71\u201378","journal-title":"Neuropharmacology"},{"key":"7164_CR49","unstructured":"Paxinos G, Watson C (2013) The Rat Brain in Stereotaxic Coordinates. Academic"},{"issue":"50","key":"7164_CR50","doi-asserted-by":"publisher","first-page":"10607","DOI":"10.1523\/JNEUROSCI.2629-16.2018","volume":"38","author":"SM Perez","year":"2018","unstructured":"Perez SM, Lodge DJ (2018) Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity. J Neurosci 38(50):10607\u201310618","journal-title":"J Neurosci"},{"key":"7164_CR51","volume-title":"Hippocampal \u03b15-GABAA receptors modulate dopamine neuron activity in the rat ventral tegmental area","author":"SM Perez","year":"2022","unstructured":"Perez SM, McCoy AM, Prevot TD, Milan MY, Carreno FR, Frazer A, Cook JM, Sibille E, Lodge DJ (2022) Hippocampal \u03b15-GABAA receptors modulate dopamine neuron activity in the rat ventral tegmental area. Global Open Access, Biological Psychiatry"},{"issue":"2","key":"7164_CR52","first-page":"84","volume":"5","author":"TD Prevot","year":"2019","unstructured":"Prevot TD, Li G, Vidojevic A, Misquitta KA, Fee C, Santrac A, Knutson DE, Stephen MR, Kodali R, Zahn NM, Arnold LA, Scholze P, Fisher JL, Markovic BD, Banasr M, Cook JM, Savic M, Sibille E (2019) Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles. Mol Neuropsychiatry 5(2):84\u201397","journal-title":"Mol Neuropsychiatry"},{"issue":"1","key":"7164_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11126-020-09797-4","volume":"92","author":"T Qassem","year":"2021","unstructured":"Qassem T, Aly-ElGabry D, Alzarouni A, Abdel-Aziz K, Arnone D (2021) Psychiatric Co-Morbidities in Post-Traumatic Stress Disorder: Detailed Findings from the Adult Psychiatric Morbidity Survey in the English Population. Psychiatr Q 92(1):321\u2013330","journal-title":"Psychiatr Q"},{"key":"7164_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0079-6123(08)63163-5","volume":"86","author":"RM Sapolsky","year":"1990","unstructured":"Sapolsky RM (1990) Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog Brain Res 86:13\u201323","journal-title":"Prog Brain Res"},{"issue":"9","key":"7164_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/070674371405900902","volume":"59","author":"J Sareen","year":"2014","unstructured":"Sareen J (2014) Posttraumatic stress disorder in adults: impact, comorbidity, risk factors, and treatment. Can J Psychiatry 59(9):460\u2013467","journal-title":"Can J Psychiatry"},{"key":"7164_CR56","doi-asserted-by":"crossref","unstructured":"Sharmin D, Mian MY, Marcotte M, Prevot TD, Sibille E, Witkin JM, Cook JM (2023) Synthesis and receptor binding studies of alpha5 gaba(a)r selective novel imidazodiazepines targeted for psychiatric and cognitive disorders. Molecules 28(12)","DOI":"10.3390\/molecules28124771"},{"key":"7164_CR57","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ejphar.2016.09.016","volume":"791","author":"TT Stamenic","year":"2016","unstructured":"Stamenic TT, Poe MM, Rehman S, Santrac A, Divovic B, Scholze P, Ernst M, Cook JM, Savic MM (2016) Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the alpha5 subunit. Eur J Pharmacol 791:433\u2013443","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"7164_CR58","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/cne.24337","volume":"526","author":"H Stefanits","year":"2018","unstructured":"Stefanits H, Milenkovic I, Mahr N, Pataraia E, Hainfellner JA, Kovacs GG, Sieghart W, Yilmazer-Hanke D, Czech T (2018) GABA(A) receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits. J Comp Neurol 526(2):324\u2013348","journal-title":"J Comp Neurol"},{"issue":"5 Pt 1","key":"7164_CR59","first-page":"E894","volume":"258","author":"GC Tombaugh","year":"1990","unstructured":"Tombaugh GC, Sapolsky RM (1990) Hippocampal glutamine synthetase: insensitivity to glucocorticoids and stress. Am J Physiol 258(5 Pt 1):E894\u2013897","journal-title":"Am J Physiol"},{"issue":"7","key":"7164_CR60","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2012.02.003","volume":"35","author":"MA Ungless","year":"2012","unstructured":"Ungless MA, Grace AA (2012) Are you or aren\u2019t you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 35(7):422\u2013430","journal-title":"Trends Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07164-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:03:40Z","timestamp":1789117420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07164-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":59,"alternative-id":["7164"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07164-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DJL has received research funding from Heptares Therapeutics Ltd., consulting fees from Alkermes Inc., and is a patent co-inventor (US 2019\/0117637). These interests are unrelated to the work described in this manuscript. All other authors declare they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}]}}